| Product Code: ETC7657789 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Opioid Receptor Agonist Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 Israel Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 Israel Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Israel Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 Israel Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Israel Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Israel |
4.2.2 Growing awareness about the benefits of opioid receptor agonists in pain management |
4.2.3 Rising geriatric population in Israel requiring pain management solutions |
4.3 Market Restraints |
4.3.1 Stringent regulatory framework governing the use of opioid receptor agonists |
4.3.2 Concerns regarding the potential for abuse and addiction associated with opioid medications |
4.3.3 Limited availability of specialized healthcare professionals for prescribing and monitoring opioid therapy |
5 Israel Opioid Receptor Agonist Market Trends |
6 Israel Opioid Receptor Agonist Market, By Types |
6.1 Israel Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Israel Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Israel Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 Israel Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 Israel Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 Israel Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 Israel Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 Israel Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 Israel Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 Israel Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Israel Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 Israel Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 Israel Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 Israel Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 Israel Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 Israel Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Israel Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Israel Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Israel Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 Israel Opioid Receptor Agonist Market Export to Major Countries |
7.2 Israel Opioid Receptor Agonist Market Imports from Major Countries |
8 Israel Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Patient adherence rate to opioid receptor agonist therapy |
8.2 Number of healthcare facilities offering opioid receptor agonist treatment options |
8.3 Rate of new product development and innovation in the opioid receptor agonist market |
9 Israel Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 Israel Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Israel Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 Israel Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Israel Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Opioid Receptor Agonist Market - Competitive Landscape |
10.1 Israel Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Israel Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here